Dyslipidemia Management in Chinese Post Stroke Patients

Completed

• Conditions: Brain Ischemia,Stoke

• Registration Number: NCT01897883
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of this study is to provide current and reliable data of dyslipidimia management together with control situation of blood pressure and glucose for post-stroke patients within 6-12 months from attack, and also the association between patient characteristics and control rate of lipids in this population.

It is an non-interventional study, no study specified treatment is required.Approximately 5000 post ischemic stroke patients within 6-12 months from attack will enter into the study. Fifty centres from different regions of China will participate in this study.

Detailed Description

This is a multicentre, cross-sectional, observational study, aiming to investigate the prevalence and control situation of dyslipidimia in China post ischemic stroke patients within 6-12 months from attack. Patients will be screened consecutively, eligible subjects will be interviewed by investigator and finish a questionire during the visit. Investigator will collect relevant medical history, physical exam results and lab test results including blood lipid (i.e. Triglyceride, Total Cholesterol, LDL-C, HDL-C) and glucose(HbA1c if available).Approximately 5000 post ischemic stroke patients within 6-12 months from attack will enter into the study. Fifty centres from different regions of China will participate in this study.

Study Timeline

• Study Start: 2013-07
• Study First Submitted: 2013-07-03
• Study First Submitted QC: 2013-07-10
• Study First Posted: 2013-07-12
• Primary Completion: 2014-08
• Study Completion: 2014-08
• Status Verified: 2015-07
• Last Update Submitted: 2015-07-29
• Last Update Posted: 2015-07-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 5000

Inclusion Criteria

1. Male or female with age ≥ 18 years
2. Post ischemic stroke patients within 6-12 months from attack
3. written informed consent is provided to participant in the study

Exclusion Criteria

1. Significant medical or psychological condition that make patients can not finish the questionnaire independently or with the aids of his/her legal representatives
2. The patient is or will be in another clinical study
3. Previous enrolment in the present study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To observe LDL-C level of China post-stroke patients within 6-12 months from attack	Up to 12 months	Investigator will collect lab test results including blood lipid (i.e. Triglyceride, Total Cholesterol, LDL-C, HDL-C) during the patient visit.
To observe control rate of LDL-C of China post-stroke patients within 6-12 months from attack	Up to 12 months

Trial Locations

Locations (1)

Research Site; 🇨🇳 Shanghai, China